| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.07 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.08 |